THE EFFECT OF LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) AND UNFRACTIONATED HEPARIN (UFH) DURING SUCCESSIVE ADMINISTRATION TO HEALTHY-SUBJECTS - CUMULATION OF ANTICOAGULANT ACTIVITY

被引:0
|
作者
KOHLER, M [1 ]
PINDUR, G [1 ]
SEYFERT, UT [1 ]
机构
[1] UNIV SAARLAND,KLIN HAMOSTASEOL & TRANSFUSIONSMED ABT,W-6650 HOMBURG,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1299 / 1299
页数:1
相关论文
共 50 条
  • [21] ANTICOAGULANT EFFECT OF A LOW-MOLECULAR-WEIGHT HEPARIN
    HARENBERG, J
    ZIMMERMAN, R
    DEVRIES, JX
    WEBER, E
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 128 (29-30): : 541 - 542
  • [22] EFFECT OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS ON PLATELETS
    VERMYLEN, JG
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1993, 19 : 20 - 21
  • [23] Homogeneous low-molecular-weight heparins with reversible anticoagulant activity
    Xu, Yongmei
    Cai, Chao
    Chandarajoti, Kasemsiri
    Hsieh, Po-Hung
    Li, Lingyun
    Pham, Truong Q.
    Sparkenbaugh, Erica M.
    Sheng, Juzheng
    Key, Nigel S.
    Pawlinski, Rafal
    Harris, Edward N.
    Linhardt, Robert J.
    Liu, Jian
    NATURE CHEMICAL BIOLOGY, 2014, 10 (04) : 248 - +
  • [24] Unfractionated heparin UFH vs. low molecular weight heparin LMWH for bridging during warfarin interruption: a metaanalysis of controlled clinical trials
    Dabbagh, O.
    Lent, M. P.
    Bearelly, S. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1072 - 1072
  • [25] Homogeneous low-molecular-weight heparins with reversible anticoagulant activity
    Xu Y.
    Cai C.
    Chandarajoti K.
    Hsieh P.-H.
    Li L.
    Pham T.Q.
    Sparkenbaugh E.M.
    Sheng J.
    Key N.S.
    Pawlinski R.
    Harris E.N.
    Linhardt R.J.
    Liu J.
    Nature Chemical Biology, 2014, 10 (4) : 248 - 250
  • [26] LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR ANTICOAGULATION DURING HEMODIALYSIS
    HORY, B
    BAYROU, B
    CLINICAL NEPHROLOGY, 1987, 28 (03) : 158 - 158
  • [27] Differential effect of low molecular weight (LMWH) and unfractionated (UFH) heparin on intravascular TFPI: A proposed mechanism for difference in antithrombotic action
    Hansen, JB
    Sandset, PM
    Huseby, KR
    Huseby, NE
    Ostergaard, P
    Nordoy, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC29 - OC29
  • [28] EFFECTS OF RECOMBINANT HIRUDIN (R-HIRUDIN) ON COAGULATION AND PLATELET ACTIVATION IN-VIVO - COMPARISON TO UNFRACTIONATED HEPARIN (UFH) AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH)
    EICHINGER, S
    WOLZT, M
    EICHLER, HG
    HEINRICHS, H
    LECHNER, K
    KYRLE, PA
    BLOOD, 1994, 84 (10) : A66 - A66
  • [29] EFFECTS OF LONG-TERM USE OF UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) ON BONE MINERAL DENSITY (BMD) IN PATIENTS WITH NEPHROTIC SYNDROME
    Monov, S. V.
    Monova, D.
    Shumnalieva, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 456 - 457
  • [30] Pharmacokinetic and pharmacodynamic properties of eptifibatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin
    Gretler, DD
    CLINICAL THERAPEUTICS, 2003, 25 (10) : 2564 - 2574